|4Mar 4, 6:07 PM ET

Grimaud Brett A. 4

4 · Theravance Biopharma, Inc. · Filed Mar 4, 2025

Insider Transaction Report

Form 4
Period: 2025-02-28
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
Transactions
  • Award

    Ordinary Shares

    2025-02-28+75,000393,811 total

Documents

1 file
  • 4
    form4-03042025_110315.xmlPrimary